carboxyatractyloside has been researched along with Liver Steatosis in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cho, J; Choi, CS; Chun, SK; Han, C; Joseph, AM; Kalavalapalli, S; Kim, JS; Lee, HY; Lee, YJ; Mathews, CE; Morgan, D; Oh, SP; Park, HJ; Park, SY; Shiratsuchi, T; Someya, S; Sunny, NE; Terada, N; Wohlgemuth, SE; Zhang, Y | 1 |
1 other study(ies) available for carboxyatractyloside and Liver Steatosis
Article | Year |
---|---|
Mitochondrial ATP transporter depletion protects mice against liver steatosis and insulin resistance.
Topics: Adenine Nucleotide Translocator 2; Adenosine Triphosphate; Animals; Atractyloside; Diet, High-Fat; Disease Models, Animal; Fatty Liver; Female; Glucose Clamp Technique; Hyperinsulinism; Insulin Resistance; Lipid Metabolism; Lipogenesis; Liver; Male; Mice; Mice, Knockout; Mitochondria, Liver; Mitochondrial Membranes; Non-alcoholic Fatty Liver Disease; Obesity; Protective Agents; Pyruvic Acid | 2017 |